The Ebola epidemic, which could affect hundreds of thousands of West Africans, can only be contained by rebuilding public trust and local health systems decimated by years of neglect, according to a panel convened by the Freeman Spogli Institute for International Studies and Stanford Medicine. FSI Senior Fellows David Relman, Paul Wise, Stephen Stedman and Douglas Owens were among the panelists.
Traditional drug repurposing, although successful in treating some diseases, still requires considerable time to identify candidate compounds and even more time to test them in clinical trials. Ebola requires and deserves a much more aggressive approach, while still balancing safety and efficacy concerns.
A National Academy of Sciences committee meets this week to study a large, growing and little-understood black market in drugs. But rather than cocaine, heroin and methamphetamine, the committee members will be discussing tobacco cigarettes.
The global black market in tobacco is estimated to supply 11.6% of the world’s consumption, a startling 650 billion cigarettes a year. And there are two components to this market that have drawn the particular...